UoM scientists invents medicine for ovarian cancer

Mysuru, June 18, 2022 (www.justkannada.in): The scientists of the Organic Chemistry department of the University of Mysore have invented a medicine compound named NPB that is given with Olaparib for ovarian cancer.
The NBP compound has reached the phase of usage as the result of four years of rigorous research. Getting approval from the Drug Control General of India is pending.
“In cases of ovarian cancer, there are several instances where the cancer cells continue to remain in the person who has undergone Cisplatin Chemotherapy. There are possibilities that cancer may recur even after removal of the tumour. In this phase the patient is given the NPB compound along with ‘Olaparib,’ to cure. Our research report is received by the nature journal. We have already obtained patent in 14 countries including America, Japan and Russia,” explained Dr. Basappa, Scientist and Nodal Officer of the Department of Chemistry, University of Mysore.
“The medicine is experimented successfully on rat by injecting the living cells of the cancer tumour. The rat is surviving from 17 days. Thus, the University of Mysore has the pride of inventing indigenous medicine compound for ovarian cancer,” Dr. Basappa explained.
Dr. Peter of the Singuwa University and Dr. Vijay Pandey have helped in the invention.
Keywords: University of Mysore/ Ovarian Cancer/ Invention/ Medicine